Sunrise Pharmaceutical does not currently market a dextroamphetamine product.
What dextroamphetamine products are available?
Dextroamphetamine is available in several forms, including immediate-release tablets and extended-release capsules. These medications are primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Common brand names for dextroamphetamine products include Dexedrine, Zenzedi, and Adderall (which contains a combination of amphetamine salts, including dextroamphetamine) [1].
Who manufactures dextroamphetamine?
Various pharmaceutical companies manufacture dextroamphetamine products. For instance, Teva Pharmaceuticals USA, Inc. manufactures dextroamphetamine sulfate extended-release capsules [2]. Vyvanse, a prodrug of dextroamphetamine, is manufactured by Takeda Pharmaceuticals U.S.A., Inc. [3].
When do dextroamphetamine patents expire?
Patent expiration dates for pharmaceutical drugs are complex and can vary depending on the specific formulation, manufacturing process, and any subsequent patents filed for improvements or new uses. Information regarding specific patent expiries for dextroamphetamine products can be found through resources like DrugPatentWatch.com [4].
Are there generic versions of dextroamphetamine?
Generic versions of dextroamphetamine are available, offering a more affordable alternative to brand-name medications. The availability of generics typically follows the expiry of patents held by the original manufacturer.
What are the risks associated with dextroamphetamine?
Like all medications, dextroamphetamine carries potential risks and side effects. These can include cardiovascular issues, psychiatric problems, and the potential for abuse and dependence. Patients and healthcare providers should carefully review the drug's prescribing information for a comprehensive list of risks [5].